These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
168 related articles for article (PubMed ID: 28334948)
1. A Phase I/II trial of continuous hepatic intra-arterial infusion of 5-fluorouracil, mitoxantrone and cisplatin for advanced hepatocellular carcinoma. Ikeda M; Okusaka T; Sato Y; Furuse J; Mitsunaga S; Ueno H; Morizane C; Inaba Y; Kobayashi T; Arai Y Jpn J Clin Oncol; 2017 Jun; 47(6):512-519. PubMed ID: 28334948 [TBL] [Abstract][Full Text] [Related]
2. A phase II trial of continuous infusion of 5-fluorouracil, mitoxantrone, and cisplatin for metastatic hepatocellular carcinoma. Ikeda M; Okusaka T; Ueno H; Takezako Y; Morizane C Cancer; 2005 Feb; 103(4):756-62. PubMed ID: 15637692 [TBL] [Abstract][Full Text] [Related]
3. Sorafenib plus low-dose cisplatin and fluorouracil hepatic arterial infusion chemotherapy versus sorafenib alone in patients with advanced hepatocellular carcinoma (SILIUS): a randomised, open label, phase 3 trial. Kudo M; Ueshima K; Yokosuka O; Ogasawara S; Obi S; Izumi N; Aikata H; Nagano H; Hatano E; Sasaki Y; Hino K; Kumada T; Yamamoto K; Imai Y; Iwadou S; Ogawa C; Okusaka T; Kanai F; Akazawa K; Yoshimura KI; Johnson P; Arai Y; Lancet Gastroenterol Hepatol; 2018 Jun; 3(6):424-432. PubMed ID: 29631810 [TBL] [Abstract][Full Text] [Related]
4. Chemotherapy using 5-fluorouracil, mitoxantrone, and cisplatin for patients with advanced hepatocellular carcinoma: an analysis of 63 cases. Yang TS; Chang HK; Chen JS; Lin YC; Liau CT; Chang WC J Gastroenterol; 2004; 39(4):362-9. PubMed ID: 15168248 [TBL] [Abstract][Full Text] [Related]
5. Repetitive short-course hepatic arterial infusion chemotherapy with high-dose 5-fluorouracil and cisplatin in patients with advanced hepatocellular carcinoma. Park JY; Ahn SH; Yoon YJ; Kim JK; Lee HW; Lee DY; Chon CY; Moon YM; Han KH Cancer; 2007 Jul; 110(1):129-37. PubMed ID: 17508408 [TBL] [Abstract][Full Text] [Related]
6. Long-term clinical outcomes of hepatic arterial infusion chemotherapy with cisplatin with or without 5-fluorouracil in locally advanced hepatocellular carcinoma. Kim BK; Park JY; Choi HJ; Kim DY; Ahn SH; Kim JK; Lee DY; Lee KH; Han KH J Cancer Res Clin Oncol; 2011 Apr; 137(4):659-67. PubMed ID: 20552225 [TBL] [Abstract][Full Text] [Related]
7. Phase I study of combination chemotherapy using sorafenib and transcatheter arterial infusion with cisplatin for advanced hepatocellular carcinoma. Hagihara A; Ikeda M; Ueno H; Morizane C; Kondo S; Nakachi K; Mitsunaga S; Shimizu S; Kojima Y; Suzuki E; Katayama K; Imanaka K; Tamai C; Inaba Y; Sato Y; Kato M; Okusaka T Cancer Sci; 2014 Mar; 105(3):354-8. PubMed ID: 24438504 [TBL] [Abstract][Full Text] [Related]
8. Hepatic arterial infusion chemotherapy using low-dose 5-fluorouracil and cisplatin for advanced hepatocellular carcinoma. Ueshima K; Kudo M; Takita M; Nagai T; Tatsumi C; Ueda T; Kitai S; Ishikawa E; Yada N; Inoue T; Hagiwara S; Minami Y; Chung H Oncology; 2010 Jul; 78 Suppl 1():148-53. PubMed ID: 20616598 [TBL] [Abstract][Full Text] [Related]
9. A randomized study of cisplatin and 5-FU hepatic arterial infusion chemotherapy with or without adriamycin for advanced hepatocellular carcinoma. Song MJ; Bae SH; Chun HJ; Choi JY; Yoon SK; Park JY; Han KH; Kim YS; Yim HJ; Um SH; Chung WJ; Hwang JS; Cho SB; Eun JR Cancer Chemother Pharmacol; 2015 Apr; 75(4):739-46. PubMed ID: 25663125 [TBL] [Abstract][Full Text] [Related]
10. Effect of hepatic arterial infusion chemotherapy of 5-fluorouracil and cisplatin for advanced hepatocellular carcinoma in the Nationwide Survey of Primary Liver Cancer in Japan. Nouso K; Miyahara K; Uchida D; Kuwaki K; Izumi N; Omata M; Ichida T; Kudo M; Ku Y; Kokudo N; Sakamoto M; Nakashima O; Takayama T; Matsui O; Matsuyama Y; Yamamoto K; Br J Cancer; 2013 Oct; 109(7):1904-7. PubMed ID: 24008659 [TBL] [Abstract][Full Text] [Related]
11. Hepatic arterial infusion chemotherapy with continuous low dose administration of cisplatin and 5-fluorouracil for multiple recurrence of hepatocellular carcinoma after surgical treatment. Okuda K; Tanaka M; Shibata J; Ando E; Ogata T; Kinoshita H; Eriguchi N; Aoyagi S; Tanikawa K Oncol Rep; 1999; 6(3):587-91. PubMed ID: 10203596 [TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety of hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma as first-line therapy. Oh MJ; Lee HJ; Lee SH Clin Mol Hepatol; 2013 Sep; 19(3):288-99. PubMed ID: 24133667 [TBL] [Abstract][Full Text] [Related]
13. Hepatic arterial infusion chemoembolization therapy for advanced hepatocellular carcinoma: multicenter phase II study. Nagamatsu H; Sumie S; Niizeki T; Tajiri N; Iwamoto H; Aino H; Nakano M; Shimose S; Satani M; Okamura S; Kuromatsu R; Matsugaki S; Kurogi J; Kajiwara M; Koga H; Torimura T Cancer Chemother Pharmacol; 2016 Feb; 77(2):243-50. PubMed ID: 26754678 [TBL] [Abstract][Full Text] [Related]
14. Phase II Study of Sorafenib Combined with Concurrent Hepatic Arterial Infusion of Oxaliplatin, 5-Fluorouracil and Leucovorin for Unresectable Hepatocellular Carcinoma with Major Portal Vein Thrombosis. He MK; Zou RH; Li QJ; Zhou ZG; Shen JX; Zhang YF; Yu ZS; Xu L; Shi M Cardiovasc Intervent Radiol; 2018 May; 41(5):734-743. PubMed ID: 29327075 [TBL] [Abstract][Full Text] [Related]
15. A multi-institutional phase II trial of hepatic arterial infusion chemotherapy with cisplatin for advanced hepatocellular carcinoma with portal vein tumor thrombosis. Ikeda M; Okusaka T; Furuse J; Mitsunaga S; Ueno H; Yamaura H; Inaba Y; Takeuchi Y; Satake M; Arai Y Cancer Chemother Pharmacol; 2013 Aug; 72(2):463-70. PubMed ID: 23812005 [TBL] [Abstract][Full Text] [Related]
16. [Effect of low dose 5-fluorouracil and cisplatin intra-arterial infusion chemotherapy in advanced hepatocellular carcinoma with decompensated cirrhosis]. Lim TY; Cheong JY; Cho SW; Sim SJ; Kim JS; Choi SJ; Choi JW; Kwon HC; Lee KM; Kim JK; Won JH; Yoo BM; Lee KJ; Hahm KB; Kim JH Korean J Hepatol; 2006 Mar; 12(1):65-73. PubMed ID: 16565607 [TBL] [Abstract][Full Text] [Related]
17. Randomized, phase II study comparing interferon combined with hepatic arterial infusion of fluorouracil plus cisplatin and fluorouracil alone in patients with advanced hepatocellular carcinoma. Yamashita T; Arai K; Sunagozaka H; Ueda T; Terashima T; Yamashita T; Mizukoshi E; Sakai A; Nakamoto Y; Honda M; Kaneko S Oncology; 2011; 81(5-6):281-90. PubMed ID: 22133996 [TBL] [Abstract][Full Text] [Related]
18. Hepatic intra-arterial cetuximab in combination with 5-fluorouracil and cisplatin as salvage treatment for sorafenib-refractory hepatocellular carcinoma. Poggi G; Montagna B; Melchiorre F; Quaretti P; Delmonte A; Riccardi A; Tagliaferri B; Sottotetti F; Di Cesare P; Stella MG; Villani L; Zorzetto M; Greco G; Cornalba G; Bernardo G Anticancer Res; 2011 Nov; 31(11):3927-33. PubMed ID: 22110221 [TBL] [Abstract][Full Text] [Related]
19. Combination chemotherapy with continuous 5-fluorouracil and low-dose cisplatin infusion for advanced hepatocellular carcinoma. Tanioka H; Tsuji A; Morita S; Horimi T; Takamatsu M; Shirasaka T; Mizushima T; Ochi K; Kiura K; Tanimoto M Anticancer Res; 2003; 23(2C):1891-7. PubMed ID: 12820474 [TBL] [Abstract][Full Text] [Related]
20. Clinical effects of intra-arterial infusion chemotherapy with cisplatin, mitomycin C, leucovorin and 5-flourouracil for unresectable advanced hepatocellular carcinoma. Lin CP; Yu HC; Cheng JS; Lai KH; Lo GH; Hsu PI; Lin CK; Chen HH; Lo CC; Liang HL; Tseng HH J Chin Med Assoc; 2004 Dec; 67(12):602-10. PubMed ID: 15779483 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]